Karen L. Tubridy, SVP, Chief Development Officer at Akebia Therapeutics, Inc. (AKBA), sold 3,454 shares at $8.70 ($30K) on 2020-02-28, disclosed to the SEC on 2020-03-02.
Open-market sale of $30k AKBA by SVP, Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |